Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
CNS Pharmaceuticals, Inc. (CNSP) had Return on Investments of -14.22% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-2.59M |
|
-- |
|
-- |
|
$2.70M |
|
$-2.70M |
|
$0.11M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-2.59M |
|
$-2.70M |
|
$-2.69M |
|
6.84M |
|
6.84M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$21.92M |
|
$0.01M |
|
$0.01M |
|
$21.94M |
|
$3.74M |
|
-- |
|
-- |
|
$3.74M |
|
$18.20M |
|
$18.20M |
|
$18.20M |
|
1.46M |
|
| Cash Flow Statement Financials | |
$-8.19M |
|
$-0.01M |
|
$20.98M |
|
$7.20M |
|
$19.98M |
|
$12.78M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.22% |
|
-14.22% |
|
-11.80% |
|
|
Return on Investments |
-14.22% |
$12.46 |
|
$-1.20 |
|
$-1.20 |
|